Nanotechnology‐based approaches for treating lysosomal storage disorders, a focus on Fabry disease-Reference-Cited by-同舟云学术

Nanotechnology‐based approaches for treating lysosomal storage disorders, a focus on Fabry disease

Published:2020-12-13 Issue:3 Volume:13 Page:
ISSN:1939-5116
Container-title:WIREs Nanomedicine and Nanobiotechnology
language:en
Short-container-title:WIREs Nanomed Nanobiotechnol

Author:

Abasolo Ibane¹^ORCID,Seras‐Franzoso Joaquin²³^ORCID,Moltó‐Abad Marc¹²⁴^ORCID,Díaz‐Riascos Vanessa¹²^ORCID,Corchero José Luis²⁵^ORCID,Pintos‐Morell Guillem²³⁴^ORCID,Schwartz Simó²³^ORCID

Affiliation:

1. Functional Validation & Preclinical Research, Drug Delivery & Targeting Group, CIBBIM‐Nanomedicine, Vall d'Hebron Institut of Research (VHIR) Universitat Autònoma de Barcelona (UAB) Barcelona Spain

2. Networking Research Center on Bioengineering Biomaterials and Nanomedicine (CIBER‐BBN) Barcelona Spain

3. Drug Delivery & Targeting Group, CIBBIM‐Nanomedicine, Vall d'Hebron Institut of Research (VHIR) Universitat Autònoma de Barcelona (UAB) Barcelona Spain

4. Division of Rare Diseases, Reference Center for Hereditary Metabolic Disorders (CSUR, XUEC, MetabERN, and CIBER‐ER) Vall d'Hebron University Hospital Barcelona Spain

5. Institut de Biotecnologia i de Biomedicina (IBB) and Department of Genetics and Microbiology Universitat Autònoma de Barcelona (UAB), Bellaterra Barcelona Spain

Funder

Fundació la Marató de TV3

Horizon 2020 Framework Programme

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wnan.1684

Reference94 articles.

1. Targeted nanoliposomes for the treatment of Fabry disease;Abasolo I.;Molecular Genetics and Metabolism,2019